Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
CLVT 
CLARIVATE PLC (CLVT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: CLVT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $5.14
1 Year Target Price $5.14
| 3 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -62.42% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.39B USD | Price to earnings Ratio - | 1Y Target Price 5.14 |
Price to earnings Ratio - | 1Y Target Price 5.14 | ||
Volume (30-day avg) 10 | Beta 1.45 | 52 Weeks Range 3.04 - 6.78 | Updated Date 10/16/2025 |
52 Weeks Range 3.04 - 6.78 | Updated Date 10/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -17.33% | Operating Margin (TTM) 9.17% |
Management Effectiveness
Return on Assets (TTM) 1.16% | Return on Equity (TTM) -8.18% |
Valuation
Trailing PE - | Forward PE 5.48 | Enterprise Value 6775388061 | Price to Sales(TTM) 0.95 |
Enterprise Value 6775388061 | Price to Sales(TTM) 0.95 | ||
Enterprise Value to Revenue 2.71 | Enterprise Value to EBITDA 9.89 | Shares Outstanding 672219064 | Shares Floating 398135185 |
Shares Outstanding 672219064 | Shares Floating 398135185 | ||
Percent Insiders 16.75 | Percent Institutions 90.06 |
Upturn AI SWOT
CLARIVATE PLC
Company Overview
History and Background
Clarivate was formed in 2016 following the acquisition of Thomson Reuters' Intellectual Property & Science business by Onex Corporation and Baring Private Equity Asia. It became a public company in 2019 through a merger with a special purpose acquisition company (SPAC). Clarivate has grown through acquisitions and organic growth to become a leading provider of information and insights.
Core Business Areas
- Science: Provides scientific and academic research information and analytics solutions.
- Intellectual Property: Offers intellectual property management and intelligence solutions, including patent research and analytics.
- Life Sciences & Healthcare: Provides data and insights for the life sciences industry.
Leadership and Structure
Jonathan Gear is the CEO. The company has a board of directors overseeing the management team. Organizational structure is based on business segments.
Top Products and Market Share
Key Offerings
- Web of Science: A comprehensive citation index providing access to research literature. Competitors include Scopus (RELX) and Google Scholar. Market Share is estimated at ~30% of scholarly citation index market. Revenue generated from subscriptions.
- Derwent Innovation: A patent database offering enhanced patent information. Key competitor is PatBase (Minesoft). Estimated market share is around ~15% of professional IP database market. Revenue generated from subscriptions.
- Cortellis: A suite of solutions for drug discovery and development in the life sciences. Competitors include Evaluate Pharma (Norvartis) and Informa Pharma Intelligence. Market Share estimated at ~5% of the overall pharma intelligence and analytics market.
Market Dynamics
Industry Overview
The industry is characterized by high demand for data, analytics, and intelligence across scientific research, intellectual property, and life sciences. Key trends include increasing digitization, data explosion, and the need for insights to drive innovation and decision-making.
Positioning
Clarivate positions itself as a leading global provider of trusted insights and analytics to accelerate the pace of innovation. It leverages its comprehensive data assets and analytical tools to provide value to its customers. Competitive advantage is their breadth of product and extensive data.
Total Addressable Market (TAM)
The TAM is estimated at $30 billion or greater. Clarivate is well positioned to capture a significant portion of this TAM through its diverse product portfolio and market presence.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Comprehensive data assets
- Diverse product portfolio
- Global presence
- Established customer relationships
Weaknesses
- High debt level
- Integration challenges from acquisitions
- Complexity of product offerings
- Reliance on subscription revenue
Opportunities
- Expanding into new markets
- Developing new products and services
- Leveraging AI and machine learning
- Acquiring complementary businesses
Threats
- Competition from larger players
- Economic downturn
- Changes in technology
- Data security breaches
- Evolving regulatory landscape
Competitors and Market Share
Key Competitors
- RELX PLC (RELX)
- Wolters Kluwer (WOLK)
- Gartner, Inc (IT)
Competitive Landscape
Clarivate competes with larger players in the information and analytics industry. Its strengths include its comprehensive data assets and diverse product portfolio, while its weaknesses include its high debt level and integration challenges.
Major Acquisitions
ProQuest (Information and Technology Solutions Professional)
- Year: 2021
- Acquisition Price (USD millions): 5300
- Strategic Rationale: Expand content coverage and analytical capabilities. This aquisition has burdened CLVT with debt.
Patient Connect
- Year: 2023
- Acquisition Price (USD millions): 186.9
- Strategic Rationale: Strengthened patient-level claims data and insights across the care continuum
Growth Trajectory and Initiatives
Historical Growth: Historically, Clarivate has grown through a combination of organic growth and acquisitions.
Future Projections: Analyst estimates project moderate revenue growth in the coming years, driven by new product development and market expansion.
Recent Initiatives: Recent initiatives include product enhancements, strategic acquisitions, and cost-cutting measures.
Summary
Clarivate is a major player in information and analytics, but it carries significant debt, largely because of acquisitions. Its comprehensive data and diverse portfolio are significant strengths, while debt levels and integrating past acquisitions are weaknesses. Future growth relies on product expansion and market penetration, but it must navigate competition and technological advancements to maintain its position. Debt reduction remains crucial to improve its financial stability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings (10K, 10Q)
- Analyst Reports
- Industry Publications
- Clarivate Investor Relations
Disclaimers:
This analysis is for informational purposes only and does not constitute investment advice. Market data and estimates are subject to change. The AI-based rating is based on an algorithm and should be used as one factor among many when making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CLARIVATE PLC
Exchange NYSE | Headquaters - | ||
IPO Launch date 2018-10-29 | CEO & Director Mr. Matitiahu Shem Tov | ||
Sector Technology | Industry Information Technology Services | Full time employees 12000 | Website https://www.clarivate.com |
Full time employees 12000 | Website https://www.clarivate.com | ||
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company provides scientific and academic research, a connect data, solutions, and expertise so that research institutions can thrive; ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats including data bases, dissertations, news, primary sources, books, and video; Alma, Polari, and Vega, a solution provides a proven, flexible, and unified library services platform for libraries to effectively manage their resources and unique materials. It offers IPFolio and FoundationIP, manages platform that allows companies to secure, manage, and protect their IP assets through advanced workflow automation technology, superior data and analytics, and unparalleled industry expertise and support; patent services; Derwent Innovation patent search software helps patent professionals make faster, more patentability, freedom-to-operate, and validity decisions; and CompuMark trademark search solutions as well as trademark watch and other managed services. In addition, the company provides Cortellis, a suite of products equip customers with the intelligence needed to make decisions spanning the entire drug development lifecycle. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.